<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="984">
  <stage>Registered</stage>
  <submitdate>17/11/2005</submitdate>
  <approvaldate>17/11/2005</approvaldate>
  <nctid>NCT00256438</nctid>
  <trial_identification>
    <studytitle>Depression and Transcranial Direct Current Stimulation (tDCS)</studytitle>
    <scientifictitle>The Treatment of Depression Using Transcranial Direct Current Stimulation (tDCS): a Pilot Study.</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>05125</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Depression</healthcondition>
    <conditioncode>
      <conditioncode1>Mental Health</conditioncode1>
      <conditioncode2>Depression</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Treatment: devices - Transcranial Direct Current Stimulation

Treatment: devices: Transcranial Direct Current Stimulation


</interventions>
    <comparator />
    <control />
    <interventioncode>Treatment: devices</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>All measures at baseline and after each 5 treatments:</outcome>
      <timepoint />
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Montgomery&amp; Asberg Depression Rating Scale</outcome>
      <timepoint />
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Hamilton Psychiatric Rating Scale for Depression</outcome>
      <timepoint />
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Clinical Global Impression-Severity</outcome>
      <timepoint />
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Beck Depression Inventory</outcome>
      <timepoint />
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Patient Global Impression-Severity</outcome>
      <timepoint />
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Neuropsychological assessment at baseline and after each 5 treatments:</outcome>
      <timepoint />
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Rey Auditory Verbal Learning Task</outcome>
      <timepoint />
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Digit span</outcome>
      <timepoint />
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Trail Making Test</outcome>
      <timepoint />
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Controlled Oral Word Association</outcome>
      <timepoint />
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>-  DSM-IV Major Depressive Episode of less than or equal to 3 years

          -  Montgomery-Asberg Depression Rating Scale score of 25 or more

          -  Aged 18-65

          -  May or may not be taking antidepressant medication</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>65</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>-  Not able to give written informed consent

          -  Failure to respond to ECT in current or past episodes of depression

          -  On antipsychotic, anticonvulsant or benzodiazepine medication which cannot be
             withdrawn.

          -  Significant other Axis I psychiatric disorder e.g schizophrenia, bipolar

          -  In imminent physical or psychological danger and needs a rapid clinical response due
             to inanition, psychosis or high suicidality

          -  Drug or alcohol dependence or abuse currently or in the last 12 months

          -  History of neurological illness e.g epilepsy; neurosurgical procedure

          -  Metal in the cranium, pacemaker, cochlear implant, medication or other electronic
             device in the body

          -  Woman of child-bearing age in whom pregnancy cannot be ruled out by B HCG</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 1/Phase 2</phase>
    <anticipatedstartdate />
    <actualstartdate>1/02/2006</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize />
    <actualsamplesize />
    <recruitmentstatus>Unknown status</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate />
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>NSW</recruitmentstate>
    <hospital>Black Dog Institute Building, School of Psychiatry, University of NSW - Sydney</hospital>
    <postcode>2031 - Sydney</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other</primarysponsortype>
    <primarysponsorname>The University of New South Wales</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
  </sponsorship>
  <ethicsAndSummary>
    <summary>Transcranial direct current stimulation (tDCS)is a non invasive technique which uses a very
      weak current to change excitability in targeted regions of the brain. Early studies suggest
      that it has antidepressant properties. This study will test the safety and efficacy of tDCS
      as a treatment for depression.</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT00256438</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Perminder P Sachdev, FRANZCP PhD</name>
      <address>University of NSW</address>
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name>Colleen K Loo, FRANZCP, MD</name>
      <address />
      <phone>02 9382 3721</phone>
      <fax />
      <email>colleen.loo@unsw.edu.au</email>
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>